Original Research
Published on 08 Jan 2024
Vitamin D3 promotes gastric cancer cell autophagy by mediating p53/AMPK/mTOR signaling
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1338260
- 2,705 views
- 3 citations
Type at least 3 characters
2,597 articles
Articles
Review
Published on 08 Jan 2024
Unveiling the landscape of cytokine research in glioma immunotherapy: a scientometrics analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1333124
- 2,423 views
- 2 citations
Original Research
Published on 08 Jan 2024
Network pharmacology and experiment validation investigate the potential mechanism of triptolide in oral squamous cell carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1302059
- 1,907 views
Systematic Review
Published on 08 Jan 2024
Efficacy and safety of docetaxel plus S-1-based therapy in gastric cancer: a quantitative evidence synthesis of randomized controlled trials
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1242548
- 1,184 views
Original Research
Published on 08 Jan 2024
Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1331687
- 1,314 views
Original Research
Published on 05 Jan 2024
Carnosol ameliorated cancer cachexia-associated myotube atrophy by targeting P5CS and its downstream pathways
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1291194
- 3,251 views
Perspective
Published on 05 Jan 2024
Cell death in cancer chemotherapy using taxanes
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1338633
- 3,121 views
- 5 citations
Review
Published on 04 Jan 2024
Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1307860
- 7,691 views
- 14 citations
Editorial
Published on 04 Jan 2024
Editorial: The role of tumor microenvironment in the development, treatment and prognosis of hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1343175
- 943 views
Brief Research Report
Published on 04 Jan 2024
Investigations of potential non-amino acid SNAT2 inhibitors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1302445
- 1,362 views
- 2 citations
Original Research
Published on 20 Dec 2023
The role of ARL4C in predicting prognosis and immunotherapy drug susceptibility in pan-cancer analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1288492
- 2,024 views
- 3 citations
Original Research
Published on 20 Dec 2023
The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1333507
- 2,245 views
- 1 citation
Review
Published on 19 Dec 2023
Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1327717
- 2,356 views
- 3 citations
Editorial
Published on 18 Dec 2023
Editorial: Recent advances in small molecule-based targeted therapy for breast cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1343664
- 1,299 views
Original Research
Published on 15 Dec 2023
Benefit assessment of extended dosing in cancer patients after their withdrawal from clinical trials
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1178002
- 970 views
Case Report
Published on 15 Dec 2023
Posterior reversible encephalopathy syndrome associated with use of anlotinib to treat squamous cell carcinoma of the cervix: case report and literature review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1255785
- 1,180 views
- 1 citation